Higher efficacy of radiotherapy equipment with enhanced clinical outcomes to drive growth of the global radiotherapy market

Google+ Pinterest LinkedIn Tumblr +

Radiotherapy market, also known as radiation therapy, uses ionizing radiations that deliver targeted beams of radiation to kill and destroy cancer cells. The advanced technology used in radiotherapy works by bombarding cancerous cells with radiation to kill them, while minimizing damage to the healthy cells around them. Radiotherapy is the most potent and cost-effective treatment for cancer, and when integrated with advanced technologies such as image guided therapy, leads to enhanced control over tumor and toxicity.

Several types of radiotherapies such as external beam radiation therapy, internal beam radiation therapy/ brachytherapy, and systemic radiation therapy, are available to combat various types of cancers prevalent globally. External beam radiation therapy is used to treat various types of cancers, including brain tumors, bladder cancer, and bone cancers. Brachytherapy is often used to treat cancers of the head and neck, breast, cervix, prostate, and eye, while systemic radiation therapy is often used to treat certain types of thyroid cancers using radioactive iodine.

Request to Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/1320

Browse 38 Market Data Tables and 26 Figures spread through 205 Pages and in-depth TOC on “Radiotherapy Market”- Global Forecast to 2025, by Product Type (External Beam Radiation, Internal Beam Radiation and Systemic Radiation), by Therapy Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy and Systemic Radiation Therapy), by Application (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Others), by End User (Hospitals, Oncology Clinics, and Ambulatory Radiotherapy Centers) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa)

Key players are adopting strategic collaborations and acquisitions for the development of radiotherapy techniques to accelerate innovation and to expand their geographical presence, thereby augmenting market growth. For instance, in 2017, Ion Beam Applications collaborated with Royal Philips to offer unique integrated solutions for proton therapy and molecular imaging centers, with an objective to enable effective and personalized cancer care. The companies collaborated to deliver proton therapy systems such as Proteus ONE and Proteus PLUS and clinical informatics solution such as Philips Big Bore CT, PET CT systems and Pinnacle3 Treatment Planning System in the UK, Middle East, and India.

Moreover, key players are launching high-quality tools for accurate and efficient radiotherapy treatment, thereby introducing novel solutions to enhance oncology radiotherapy. For instance, in 2017, Toshiba Medical introduced Galan RT Solutions suite of radiation therapy tools, which include the advanced Universal Couchtop MR Overlay from Civco Radiotherapy to help improve patient safety by sparing healthy tissue from unnecessary radiation. Galan RT Solutions allow health care providers to precisely map MR data to PET/CT images to develop radiation therapy plans, thus prioritizing patient care.

Key Takeaways of the Radiotherapy Market:

The global radiotherapy market is expected to exhibit a CAGR of 6.8% over the forecast period, owing to the rising recommendations by oncologists as radiotherapy has higher potential to eliminate cancer as well as increasing prevalence of cancer in Europe, Asia Pacific, and Latin America

Among product types, the external beam radiation segment holds a dominant position in the radiotherapy market, owing to the rising adoption of linear accelerators, product enhancements, and increasing adoption of external beam radiotherapy devices in emerging economies such as India, Brazil, and China

Among applications, the lung segment holds a dominant position in the radiotherapy market, owing to the larger number of patient pool diagnosed with the condition and the increasing availability of innovative external and internal beam radiotherapies to treat the condition

Among end users, the hospitals segment holds a dominant position, owing to the higher adoption and availability of the advanced radiotherapy systems offering enhanced care

Ask for customization: https://www.coherentmarketinsights.com/insight/request-customization/1320

Some of the major players operating in the global radiotherapy market are Accuray Incorporated, Varian Medical Systems, Inc., Elekta AB, Ion Beam Applications S.A., C.R. Bard, Inc., Isoray Medical, Inc., CIVCO Radiotherapy, Hitachi Ltd., Mevion Medical Systems, Inc., and ProTom International, Inc.


About Author

Is a technology enthusiast, who has amassed a wide range of experience in the industry at a very young age. His extensive background of computer software and programming and proclivity to be up-to-date with the latest of technology upgrades and launches, helps him deliver the most intriguing and trending tech news. Contact Author

Comments are closed.